Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideya Yamazaki

Showing results (51-60 of 212) with videos related to

Pageof 22
Sort By:
Anticancer Research|April 3, 2014
Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancerKen Yoshida, Hideya Yamazaki, Satoaki Nakamara, et al.
Anticancer Research|June 13, 2014
Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapyKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Cureus|March 21, 2022
Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary GlandsHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Journal of Radiation Research|April 7, 2011
Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgeryTadayuki Kotsuma, Ken Yoshida, Hideya Yamazaki, et al.
Japanese Journal of Clinical Oncology|October 3, 2003
Four cases of central nervous system involvement of breast malignant lymphomaHideya Yamazaki, Masato Hanada, Masashi Kitada, et al.
Journal of Radiation Research|January 8, 2013
Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experienceKana Kobayashi, Koji Okihara, Tsuyoshi Iwata, et al.
Anticancer Research|January 10, 2014
Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor locationGen Suzuki, Hideya Yamazaki, Etsuyo Ogo, et al.
Journal of Medical Case Reports|June 3, 2014
Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case reportTakuya Nishimura, Hideya Yamazaki, Kazuki Iwama, et al.
Anticancer Research|July 31, 2014
Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancerKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Anticancer Research|December 27, 2017
Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated RadiotherapyNaomi Sasaki, Hideya Yamazaki, Daisuke Shimizu, et al.
Pageof 22

Showing results (51-60 of 212) with videos related to

Sort By:
Pageof 22
Anticancer Research|April 3, 2014
Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancerKen Yoshida, Hideya Yamazaki, Satoaki Nakamara, et al.
Anticancer Research|June 13, 2014
Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapyKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Cureus|March 21, 2022
Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary GlandsHideya Yamazaki, Gen Suzuki, Norihiro Aibe, et al.
Journal of Radiation Research|April 7, 2011
Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgeryTadayuki Kotsuma, Ken Yoshida, Hideya Yamazaki, et al.
Japanese Journal of Clinical Oncology|October 3, 2003
Four cases of central nervous system involvement of breast malignant lymphomaHideya Yamazaki, Masato Hanada, Masashi Kitada, et al.
Journal of Radiation Research|January 8, 2013
Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experienceKana Kobayashi, Koji Okihara, Tsuyoshi Iwata, et al.
Anticancer Research|January 10, 2014
Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor locationGen Suzuki, Hideya Yamazaki, Etsuyo Ogo, et al.
Journal of Medical Case Reports|June 3, 2014
Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case reportTakuya Nishimura, Hideya Yamazaki, Kazuki Iwama, et al.
Anticancer Research|July 31, 2014
Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancerKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Anticancer Research|December 27, 2017
Long-term Outcomes of a Dose-reduction Trial to Decrease Late Gastrointestinal Toxicity in Patients with Prostate Cancer Receiving Soft Tissue-matched Image-guided Intensity-modulated RadiotherapyNaomi Sasaki, Hideya Yamazaki, Daisuke Shimizu, et al.
Pageof 22